Steinhart Richard I Insider Trades

Insider Trading History

Track insider trading activity for Steinhart Richard I. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Financial Officer
Holding Value $32.3k 26,300 shares
Last Trade
May 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.46k 6,845 shares
$1.09
$1.23
Atossa Therapeutics
Atossa Therapeutics ATOS
Director
Holding Value $48.5k 10,000 shares
Last Trade
May 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$51.6k 10,000 shares
$5.16
$4.85
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Financial Officer
Holding Value $40.8k 33,145 shares
Last Trade
May 04, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$22.1k 17,500 shares
$1.26
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Financial Officer
Holding Value $64.6k 52,500 shares
Last Trade
May 04, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$22.1k 17,500 shares
$1.26
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Financial Officer
Holding Value $19.2k 15,645 shares
Last Trade
May 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.8k 9,000 shares
$1.20
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
May 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.8k 9,000 shares
$1.20
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Financial Officer
Holding Value $304 247 shares
Last Trade
Mar 15, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$52.2 35 shares
$1.49
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Financial Officer
Holding Value $8.17k 6,645 shares
Last Trade
Mar 15, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$52.2 35 shares
$1.49
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Financial Officer
Holding Value $119 97 shares
Last Trade
Mar 14, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$49.2 33 shares
$1.49
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Financial Officer
Holding Value $8.13k 6,610 shares
Last Trade
Mar 14, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$49.2 33 shares
$1.49
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Financial Officer
Holding Value $86.4k 70,282 shares
Last Trade
Jan 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112k 70,000 shares
$1.60
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Financial Officer
Holding Value $347 282 shares
Last Trade
Dec 15, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$65.6 35 shares
$1.88
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Financial Officer
Holding Value $8.09k 6,577 shares
Last Trade
Dec 15, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$65.6 35 shares
$1.88
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Financial Officer
Holding Value $8.05k 6,542 shares
Last Trade
Dec 14, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$66.3 33 shares
$2.01
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Financial Officer
Holding Value $160 130 shares
Last Trade
Dec 14, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$66.3 33 shares
$2.01
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Financial Officer
Holding Value $8.01k 6,509 shares
Last Trade
Sep 15, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$111 35 shares
$3.17
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Financial Officer
Holding Value $390 317 shares
Last Trade
Sep 15, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$111 35 shares
$3.17
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Financial Officer
Holding Value $200 163 shares
Last Trade
Sep 14, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$103 33 shares
$3.11
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Financial Officer
Holding Value $7.96k 6,474 shares
Last Trade
Sep 14, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$103 33 shares
$3.11
$1.23
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Financial Officer
Holding Value $11.1k 9,000 shares
Last Trade
Aug 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.3k 9,000 shares
$1.37
$1.23

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up